CHRU de Brest
Brest, 29609, France
NCT Number: NCT02897310
This study assess the vital status, renal function and renal recovery of patients admitted to intensive care unit and requiring renal replacement therapy for acute kidney failure. Patient follow up is up to 3 years after ICU admission when possible.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, 29609, France
Up to 50% of critically ill patients develop acute kidney injury and up to 10% require renal replacement therapy in the intensive care unit. This study aims to identify factors associated with mortality and to evaluate renal recovery of patients who had acute kidney failure requiring renal replacement therapy in intensive care unit at 1 and 3 years post intensive care unit admission.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: year 1
vital status
Time frame: year 1
Time frame: Year one
University Hospital, Brest
Other
Acronym: PROVEER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04962412
Acute Kidney Injury, Critical Illness
Shanghai, China
View Trial DetailsNCT07195565
Acute Kidney Injury, Burns
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05458063
Acute Kidney Injury, Critical Illness
Wŏnju, Gangwon-do, South Korea
View Trial DetailsNCT04997915
Acute Kidney Injury, COVID-19
Antwerp, Belgium
View Trial Details